Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis

Jan 15, 2019Pathology, research and practice

miR-375 as a possible marker to predict outcomes in esophageal squamous cell cancer based on genetic data and meta-analysis

AI simplified

Abstract

A total of 129 differentially expressed miRNAs were identified between esophageal squamous cell cancer and adjacent normal tissue.

  • Eight of the differentially expressed miRNAs are associated with the prognosis of patients with esophageal squamous cell cancer.
  • Gene Set Enrichment Analysis revealed significant alterations in three gene sets related to miR-375 expression levels.
  • The role of miR-375, along with its four candidate target genes, was examined to understand its involvement in the development and progression of esophageal squamous cell cancer.
  • Meta-analysis confirmed the prognostic value of miR-375 in esophageal squamous cell cancer.
  • Findings suggest that miR-375 functions as a tumor suppressor and may serve as an independent prognostic factor.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free